Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L4OW
|
||||
Former ID |
DNC011174
|
||||
Drug Name |
GANSTIGMINE
|
||||
Indication | Discovery agent | Investigative | [529473] | ||
Structure |
Download2D MOL |
||||
Canonical SMILES |
CCC1=CC=CC=C1NC(=O)OC2=CC3=C(C=C2)N(C4C3(CC[N+]4(C)[O-]<br />)C)C.Cl
|
||||
InChI |
1S/C22H27N3O3.ClH/c1-5-15-8-6-7-9-18(15)23-21(26)28-16-10-11-19-17(14-16)22(2)12-13-25(4,27)20(22)24(19)3;/h6-11,14,20H,5,12-13H2,1-4H3,(H,23,26);1H/t20-,22-,25?;/m0./s1
|
||||
InChIKey |
GPQRGFUTRVNTHA-QFPJJMDASA-N
|
||||
Target and Pathway | |||||
Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [529473] | |
KEGG Pathway | Glycerophospholipid metabolism | ||||
Cholinergic synapse | |||||
Pathway Interaction Database | ATF-2 transcription factor network | ||||
PathWhiz Pathway | Phospholipid Biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.